A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.

Cardiol Ther · 2015 · PMC4675753 · PMID 26396083

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

The SYNERGY (Superior Yield of the New strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa inhibitors) trial demonstrated a nonsignificant trend of increased TIMI major and GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) severe bleeding with enoxaparin compared with UFH, but similar rates of death or myocardial infarction in elderly patients [ 46 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.